Table 4

Administration of radiochemotherapy
Dose level
1 2 3 Total
Number of patients 4 (100%) 13 (100%) 7 (100%) 24 (100%)
Chemotherapy delay?
  No 3 (75%) 5 (38%) 5 (71%) 13 (54%)
  Yes 1 (25%) 8 (62%) 2 (29%) 11 (46%)
If yes, reason for delay:
  Administrative reason 1 (100%) 4 (50%) 1 (50%) 6 (55%)
  Adverse event 4 (50%) 1 (50%) 5 (45%)
Chemotherapy reduction?
  No 3 (75%) 11 (85%) 6 (86%) 20 (83%)
  Yes 1 (25%) 2 (15%) 1 (14%) 4 (17%)
If so, reason for reduction:
  Administrative reason 1 (50%) 1 (25%)
  Adverse event 1 (100%) 1 (50%) 1 (100%) 3 (75%)
Radiotherapy total dose (Gy)
  Mean (SD) 46.8 (4.41) 44.45 (10.68) 46.54 (2.63) 45.45 (8.07)
  Median (range) 47.7 (41.4–50.4) 45.0 (10.8–50.4) 45.0 (45.0–50.4) 45.0 (10.8–50.4)

Moehler et al.

Moehler et al. BMC Cancer 2013 13:75   doi:10.1186/1471-2407-13-75

Open Data